Study of the Safety, Tolerability, Pharmacokinetics of VV913 Capsules in Chinese Healthy Participants
NCT07372703 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 56
Last updated 2026-05-04
Summary
This is a randomized, double-blind, placebo-controlled, single ascending-dose study to evaluate the safety, tolerability and pharmacokinetics characteristics of VV913 Capsules in healthy adults.
Conditions
- Healthy Volunteers
Interventions
- DRUG
-
VV913 1mg group
6 participants will receive VV913 1mg orally; 2 participants will receive placebo orally.
- DRUG
-
VV913 2mg group
6 participants will receive VV913 2mg orally; 2 participants will receive placebo orally.
- DRUG
-
VV913 4mg group
6 participants will receive VV913 4mg orally; 2 participants will receive placebo orally.
- DRUG
-
VV913 8mg group
6 participants will receive VV913 8mg orally; 2 participants will receive placebo orally.
- DRUG
-
VV913 15mg group
6 participants will receive VV913 15mg orally; 2 participants will receive placebo orally.
- DRUG
-
VV913 25mg group
6 participants will receive VV913 25mg orally; 2 participants will receive placebo orally.
- DRUG
-
VV913 40mg group
6 participants will receive VV913 40mg orally; 2 participants will receive placebo orally.
Sponsors & Collaborators
-
Vigonvita Life Sciences
lead INDUSTRY
Principal Investigators
-
Huan Zhou · The First Affiliated Hospital of Anhui Medical University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-01-29
- Primary Completion
- 2026-09-30
- Completion
- 2026-10-31
Countries
- China
Study Locations
More Related Trials
-
Single Rising Dose Study of BI 207127 NA in Healthy Male Asian Volunteers and Single Dose Study of BI 207127 NA in Healthy Male Caucasian Volunteers
NCT01347086 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-42165279 in Healthy Young and Elderly Participants
NCT01964651 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-38877618 in Healthy Male Participants
NCT01964872 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult Subjects
NCT01217918 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate The Safety, Tolerability and Pharmacokinetics Of Multiple Ascending Oral Doses Of WCK 4873 In Healthy Adult Volunteers
NCT03979859 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Adverse Events, Tolerability, and How Oral Doses of ABBV-932 Moves Through the Body in Healthy Adult Chinese Participants
NCT07024797 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of IW-6463 in Healthy Volunteers
NCT03856827 ·Status: COMPLETED ·Phase: PHASE1
-
This Study is Done in Healthy Chinese and Japanese Volunteers; it Looks at How BI 690517 is Taken up in the Body and How Well it is Tolerated
NCT03206632 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-64264681 in Healthy Male and Female Participants
NCT03607513 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Administration of HS-10356 in Healthy Volunteers
NCT04652297 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase I, First-In-Human Study of TT-00920 in Healthy Subjects
NCT04364789 ·Status: COMPLETED ·Phase: PHASE1
-
A Single and Multiple-Ascending Dose Study of CRN01941 in Healthy Adult Volunteers
NCT03936166 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7806881 in Healthy Participants
NCT07271693 ·Status: RECRUITING ·Phase: PHASE1
-
The Safety, Tolerability And Pharmacokinetics Of Single Ascending Doses And The Effect Of Food On Oral WCK 4873 In Healthy Adult Volunteers
NCT03926962 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics Study of Multiple Ascending Doses and Food Effect of LV232 Capsules
NCT06279533 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HS-20004 in Healthy Chinese Volunteers
NCT02746302 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of BI 113608 in Healthy Asian and Caucasian Male Volunteers
NCT01922349 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of RO6864018 in Male, Healthy, Asian Participants
NCT02015715 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of JNJ-77242113 Following Oral Administration in Healthy Chinese Adult Participants
NCT05703841 ·Status: COMPLETED ·Phase: PHASE1
-
A Single and Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of JNJ-42165279 in Healthy Japanese Male Participants
NCT03564379 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Dose of TT-00920 in Healthy Subjects
NCT05043792 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety and Tolerability of Single and Multiple Ascending Doses of Oral RO7020531 in Chinese Healthy Participants.
NCT03530917 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Randomised, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-910 in Healthy Participants
NCT06897813 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Study Evaluating the Safety, Tolerability and Pharmacokinetics of NSA-789 in Healthy Japanese Male Subjects
NCT00619736 ·Status: COMPLETED ·Phase: PHASE1
-
Single and Multiple Ascending Dose Study of JW1601 for Healthy Volunteers
NCT04018170 ·Status: COMPLETED ·Phase: PHASE1